Telehealth Oncofertility Care for Young Cancer Patients
This study is evaluating a "multi-component oncofertility care intervention" for young people (ages 0-50) with cancer. This intervention uses telehealth (care provided remotely, like through video calls) to help you understand and access options for preserving your fertility. It includes an electronic health record screening, telehealth counseling, and financial navigation. The researchers want to see if this intervention helps more young cancer patients engage in fertility preservation care that aligns with their goals. They will measure this 12 weeks after your oncology visit, and also look at how much conflict you feel about making these decisions.
- Study design
- This interventional study plans to enroll 2800 participants. The study status is currently unclear.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoints are measured at 12 weeks after your oncology visit.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
At a glance
Conditions
Where it's being run
4 sites across 1 statesStudy leadership
- H. Irene Su, MD, MSCE · PRINCIPAL_INVESTIGATOR · University of California, San Diego
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Number of reproductive-aged female and male patients (aged 12 to 39 years) who engage in goal-concordant oncofertility care12 weeks after oncology visit
The proportion of eligible reproductive-aged male and female patients (aged 12 to 39 years) who engage in oncofertility services (1\| an oncofertility needs screen, 2\| referral to oncofertility consult, 3\| oncofertility consult, and/or 4\| fertility preservation services) that meet the patient's individual needs will be abstracted from medical records using standardized case report forms.
- Decisional Conflict12 weeks after oncology visit
The 16-item Decisional Conflict Scale (DCS) will be used to measure patients' decisional conflict for engaging in fertility preservation services. The DCS consists of 16 statements with 5 response options (ranging from strongly agree to strongly disagree) that measures the patient's perceptions of uncertainty in choosing options, feeling informed, values clarity, support in decision making, and effective decision making. The DCS total score will be dichotomized at 37.5 (scale 0-100; \> 37.5 indicates high decisional conflict).